IPO Ideas
Medistep Healthcare Limited IPO logo

Medistep Healthcare Limited IPO

FPSMENSEListed
Listed at
53
+23.26%

Medistep Healthcare Limited IPO is a SME fixed price IPO. Price band is ₹43 per share. Minimum investment is ₹2.58 L. Lot size is 3000 shares. Open from 8 Aug 2025 to 12 Aug 2025. Allotment on 13 Aug 2025. Listing on 18 Aug 2025 at NSE. Managed by Fast Track Finsec Pvt Ltd. Registrar: Cameo Corporate Services Limited. Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents:DRHP.

Medistep Healthcare Limited IPO overview

Medistep Healthcare Limited IPO Key figures

Price band, lot, minimum application, and issue window at a glance.

Price band
₹43
Lot size
3000 shares / lot
Min investment
₹2,58,000
Issue open – close
8 Aug 2025 → 12 Aug 2025

Medistep Healthcare Limited IPO important dates

Issue Opens
8 Aug 2025
Issue Closes
12 Aug 2025
Allotment
13 Aug 2025
Listing
18 Aug 2025

Medistep Healthcare Limited IPO lot size

CategoryLotsSharesAmount
Retail (Min)26,0002,58,000
S-HNI (Min)39,0003,87,000
S-HNI (UPI)39,0003,87,000
S-HNI (Max)721,0009,03,000
B-HNI (Min)824,00010,32,000

About Medistep Healthcare Limited IPO

From the company / RHP narrative.

Incorporated in June 2023, Medistep Healthcare Limited is a pharmaceutical company producing sanitary pads, energy powder, and various pharmaceutical, nutraceutical, intimate, and surgical products. They are committed to quality and seek to expand their product line as a public, non-government company.

The product includes the followings:-


Sanitary Pads: Medistep produces high-quality sanitary pads, addressing essential feminine hygiene needs.
Energy Powder: The company manufactures energy supplements designed to revitalize and invigorate consumers.
Pharmaceutical Products: Medistep engages in the trading of various pharmaceutical items, ensuring accessibility to essential medications.
Nutraceutical Products: They offer products that blend nutrition and pharmaceuticals, promoting overall health and wellness.
Intimate Care and Hygiene Products: The company provides personal hygiene and intimate care products.
Surgical Products: Medistep supplies surgical items and supports medical professionals with necessary tools and equipment.


As of December 30, 2024, Medistep reported annualized revenues of ₹45.00 crore and a Profit After Tax (PAT) of ₹4.08 crore.

As of December 28, 2024, the company has nine employees on payroll. Labour needs depend on daily-paid labourers, and none are on contract.

Competitive Strength:


Experienced Promoters and Management Team.
Maximize resources for quality supply and cost savings through economies of scale.
Offers various products, including trading in pharmaceutical and healthcare items, manufacturing DRYSTEP sanitary pads, and VITASTEP Z energy powders.

Objective of the issue

How the issuer plans to use IPO proceeds.

Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility

Working Capital requirements

General Corporate Purpose
Medistep Healthcare Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.

Documents & links

Prospectus, draft filings, and company site open in a new tab.

Registrar

Details about the registrar of the issue.

Registrar Name
Cameo Corporate Services Limited
Phone
4428460390
Address
Cameo Corporate Services Ltd., Subramanian Building # 1, Club House Road, Chennai 600 002 - India

Issue details

Key details about the issue, including the face value, lot size, and minimum investment.

Issue Type
FP
Face Value
10
Lead Managers
Fast Track Finsec Pvt Ltd
Min Quantity
6,000
Company Promoters
Girdhari Lal Prajapat,Dabhi Vipul Gobarbhai,Prajapati Hetalben Girdharilal,Jagdish Prajapati
Phone
+91 87808 46963
Address
Medistep Healthcare Ltd. 05, S. No-245/B, Plot-19, T.P.S. 56, Free Way Trade Center, Nr.A-One Hotel N.H.-8 Narol Gam, Narol Daskroi, Ahmedabad, Gujarat, 382405

Related articles

Research posts and updates that reference this company or theme.

Follow IPO & unlisted research in the app, available on iOS and Android.